
Home » Astex Pharma Ends Development of Lung Cancer Drug
Astex Pharma Ends Development of Lung Cancer Drug
September 24, 2012
Cancer drugmaker Astex Pharmaceuticals said it would discontinue the development of its experimental small-cell lung cancer drug, Amuvatinib, as the drug failed to achieve a high enough response rate in patients in a mid-stage study.
Reuters
Reuters
Upcoming Events
-
26Jan
-
27Jan
-
27Jan
-
09Feb
-
10Feb
-
11Feb